The Centers for Disease Control and Prevention is continually striving to identify and promote best practices in laboratory medicine. As part of this effort, the Laboratory Medicine Best Practices (LMBP™) Workgroup conducts one systematic review each year to identify, evaluate, and recommend best practices for the field.

This year, the LMBP focus is on iatrogenic anemia (IA). In addition to appointing an Evidence Review Panel to assist in reviewing and locating published studies, the agency is seeking input from laboratories and healthcare professionals who have assessed the impact of their interventions that have reduced the risk for IA among patients in ICUs and NICUs.

"We will work with the expert panel to identify sources of unpublished data, such as internal QA data from hospitals or data from completed but unpublished studies," says Mark L Graber, MD, FACP, who is coordinating the Expert Panel. "We would love to hear from Phlebotomy Today readers who might have unpublished data in this regard.

Readers with pertinent information can contact Dr. Graber at [email protected].